Authors: Vicentini, CB Guarneri, M Andrisano, V Guccione, S Langer, T Marschhofer, R Chabin, R Edison, AM Huang, X Knight, WB Giori, P

Citation: Cb. Vicentini et al., Potential of pyrazolooxadiazinone derivatives as serine protease inhibitors, J ENZ INHIB, 16(1), 2001, pp. 15

Authors: Rusnak, DW Affleck, K Cockerill, SG Stubberfield, C Harris, R Page, M Smith, KJ Guntrip, SB Carter, MC Shaw, RJ Jowett, A Stables, J Topley, P Wood, ER Brignola, PS Kadwell, SH Reep, BR Mullin, RJ Alligood, KJ Keith, BR Crosby, RM Murray, DM Knight, WB Gilmer, TM Lackey, K

Citation: Dw. Rusnak et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer, CANCER RES, 61(19), 2001, pp. 7196-7203

Authors: Tian, GC Gory, M Smith, AA Knight, WB

Citation: Gc. Tian et al., Structural determinants for potent, selective dual site inhibition of human pp60(c-src) by 4-anilinoquinazolines, BIOCHEM, 40(24), 2001, pp. 7084-7091